Still calculating financial ratios manually?
Stop wasting time — let the computer do it!
2seventy bio, Inc. (TSVT) Financial Statements (2026 and earlier)
Company Profile
| Business Address |
60 BINNEY STREET CAMBRIDGE, MA 02210 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 3/31/2025 Q1 | 12/31/2024 Q4 | 9/30/2024 Q3 | 6/30/2024 Q2 | 3/31/2024 Q1 | 12/31/2023 Q4 | 9/30/2023 Q3 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 71,244 | 59,984 | 111,864 | 56,792 | 74,958 | 90,226 | |||
| Cash and cash equivalent | 71,244 | 59,984 | 111,864 | 56,792 | 74,958 | 90,226 | |||
| Receivables | 7,781 | 22,275 | 18,125 | 11,977 | 13,411 | 19,515 | |||
| Prepaid expense | 4,721 | 3,805 | 4,873 | 6,697 | 7,365 | 7,120 | |||
| Asset, held-for-sale, not part of disposal group | 12,786 | ||||||||
| Other undisclosed current assets | 103,510 | 132,415 | 90,009 | 124,590 | 142,031 | 160,393 | |||
| Total current assets: | 187,256 | 218,479 | 224,871 | 212,842 | 237,765 | 277,254 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 204,391 | 205,724 | 210,460 | 215,317 | 219,958 | 224,553 | |||
| Property, plant, and equipment, after accumulated depreciation, depletion, and amortization | 33,759 | 35,237 | 36,719 | 38,234 | 58,150 | 60,681 | |||
| Intangible asset, including goodwill, after accumulated amortization | 5,885 | 6,063 | 6,240 | 6,417 | (5,506) | 6,771 | |||
| Goodwill | (12,100) | ||||||||
| Intangible asset, excluding goodwill, after accumulated amortization | 5,885 | 6,063 | 6,240 | 6,417 | 6,594 | 6,771 | |||
| Other undisclosed noncurrent assets | 48,219 | 38,343 | 39,606 | 38,241 | 55,059 | 71,547 | |||
| Total noncurrent assets: | 292,254 | 285,367 | 293,025 | 298,209 | 327,661 | 363,552 | |||
| TOTAL ASSETS: | 479,510 | 503,846 | 517,896 | 511,051 | 565,426 | 640,806 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 13,891 | 19,884 | 17,277 | 20,541 | 23,002 | 32,027 | |||
| Accounts payable | 1,055 | 5,076 | 2,995 | 8,801 | 6,028 | 5,307 | |||
| Accrued liabilities | 12,836 | 14,808 | 14,282 | 11,740 | 16,974 | 26,720 | |||
| Deferred revenue | 16,336 | 15,403 | 13,026 | ||||||
| Other undisclosed current liabilities | 26,201 | 24,211 | 29,927 | 23,529 | 21,374 | 22,955 | |||
| Total current liabilities: | 40,092 | 44,095 | 47,204 | 60,406 | 59,779 | 68,008 | |||
| Noncurrent Liabilities | |||||||||
| Liabilities, other than long-term debt | 228,612 | 231,649 | 235,888 | 243,206 | 250,347 | 266,376 | |||
| Deferred revenue | 2,450 | 3,918 | 16,077 | ||||||
| Other liabilities | 1,260 | 685 | 2,416 | 2,409 | |||||
| Operating lease, liability | 227,352 | 231,649 | 235,888 | 240,071 | 244,013 | 247,890 | |||
| Total noncurrent liabilities: | 228,612 | 231,649 | 235,888 | 243,206 | 250,347 | 266,376 | |||
| Total liabilities: | 268,704 | 275,744 | 283,092 | 303,612 | 310,126 | 334,384 | |||
| Equity | |||||||||
| Equity, attributable to parent | 210,806 | 228,102 | 234,804 | 207,439 | 255,300 | 306,422 | |||
| Common stock | 5 | 5 | 5 | 5 | 5 | 5 | |||
| Additional paid in capital | 779,176 | 776,736 | 774,046 | 771,660 | 766,716 | 761,728 | |||
| Accumulated other comprehensive income (loss) | 89 | 305 | (236) | (336) | (204) | (916) | |||
| Accumulated deficit | (568,464) | (548,944) | (539,011) | (563,890) | (511,217) | (454,395) | |||
| Total equity: | 210,806 | 228,102 | 234,804 | 207,439 | 255,300 | 306,422 | |||
| TOTAL LIABILITIES AND EQUITY: | 479,510 | 503,846 | 517,896 | 511,051 | 565,426 | 640,806 | |||
Income Statement (P&L) ($ in thousands)Annual | Quarterly
| 3/31/2025 Q1 | 12/31/2024 Q4 | 9/30/2024 Q3 | 6/30/2024 Q2 | 3/31/2024 Q1 | 12/31/2023 Q4 | 9/30/2023 Q3 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 2,926 | 13,534 | 8,967 | 12,435 | 10,684 | 12,034 | ||
| Cost of revenue | (8,143) | (5,971) | (4,766) | (3,279) | (2,502) | (5,013) | ||
| Gross profit: | (5,217) | 7,563 | 4,201 | 9,156 | 8,182 | 7,021 | ||
| Operating expenses | (18,049) | (21,504) | (31,270) | (60,310) | (68,118) | (84,989) | ||
| Operating loss: | (23,266) | (13,941) | (27,069) | (51,154) | (59,936) | (77,968) | ||
| Nonoperating income (expense) (Other Nonoperating Income (Expense)) | 1,114 | 1,153 | 1,434 | 646 | (534) | 2,704 | ||
| Loss from continuing operations before equity method investments, income taxes: | (22,152) | (12,788) | (25,635) | (50,508) | (60,470) | (75,264) | ||
| Other undisclosed income (loss) from continuing operations before income taxes | 2,632 | 2,855 | 50,514 | (2,165) | 3,648 | 3,626 | ||
| Net income (loss) available to common stockholders, diluted: | (19,520) | (9,933) | 24,879 | (52,673) | (56,822) | (71,638) | ||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 3/31/2025 Q1 | 12/31/2024 Q4 | 9/30/2024 Q3 | 6/30/2024 Q2 | 3/31/2024 Q1 | 12/31/2023 Q4 | 9/30/2023 Q3 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (19,520) | (9,933) | 24,879 | (52,673) | (56,822) | (71,638) | ||
| Other comprehensive income (loss) | 541 | 100 | (132) | 514 | ||||
| Other undisclosed comprehensive income | 293 | 2,673 | ||||||
| Comprehensive income (loss): | (19,227) | (9,392) | 24,979 | (52,805) | (54,149) | (71,124) | ||
| Other undisclosed comprehensive loss, net of tax, attributable to parent | (509) | (1,961) | ||||||
| Comprehensive income (loss), net of tax, attributable to parent: | (19,736) | (9,392) | 24,979 | (52,805) | (56,110) | (71,124) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.
An easy way to get professional financial analysis in one click
Load financial statements → click "Get report" → Your report is ready.
No financial analysis knowledge required!